Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
Crossref DOI link: https://doi.org/10.1038/tp.2016.195
Published Online: 2016-10-18
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seeman, P
Text and Data Mining valid from 2016-10-18
Version of Record valid from 2016-10-18
Article History
Received: 11 May 2016
Revised: 7 August 2016
Accepted: 18 August 2016
First Online: 18 October 2016
Competing interests
: The author declare no conflict of interest.